Zosano Pharma Corp Net Change in Cash
Zosano Pharma Corp reported Net Change in Cash of $2.49 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2022-05-13
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was $2.49M.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was -$8.38M, a 168.47% decline year-over-year.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was $12.24M.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$3.00M.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was -$24.22M, a 183.67% decline from fiscal 2020.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $28.95M.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$2.82M.
- Zosano Pharma Corp cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2018 was -$2.51M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2022-03-31 | $2.49M 10-Q · filed 2022-05-13 | |||
| 2021-12-31 | -$24.22M 10-K · filed 2022-03-17 | |||
| 2021-09-30 | -$18.12M 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | -$13.21M 10-Q · filed 2021-08-10 | |||
| 2021-03-31 | -$8.38M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $28.95M 10-K · filed 2022-03-17 | |||
| 2020-09-30 | $37.24M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $4.23M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | $12.24M 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | -$2.82M 10-K · filed 2021-03-11 | |||
| 2019-09-30 | -$2.65M 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $5.11M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$3.00M 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | -$2.51M 10-K · filed 2020-03-13 | |||
| 2018-09-30 | $311.00K 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | $4.55M 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | -$8.11M 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | -$3.07M 10-K · filed 2019-03-25 | |||
| 2017-09-30 | -$1.71M 10-Q · filed 2018-11-15 | |||
| 2017-06-30 | $6.16M 10-Q · filed 2018-08-09 |